Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B
This study has been completed.
Information provided by:
First received: August 18, 2005
Last updated: March 1, 2007
Last verified: March 2007
This study is being conducted to compare the effectiveness and safety of telbivudine (LdT) and lamivudine in Chinese adults.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Phase III Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Idenix Pharmaceuticals:
Contacts and Locations